secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scopus BioPharma Inc. (—)
CIK:        0001772028
Form:       8-K
Filed at:   2022-12-16T23:59:59+00:00
Accession:  0001104659-22-127517
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Scopus BioPharma receives Nasdaq delisting notice; trading suspended Dec 19
---------------------------------------------------------------------------

- Nasdaq Panel determined to delist SCPS after company failed to meet compliance milestones, including a specified financing transaction.
- Nasdaq trading will be suspended effective at the open on December 19, 2022.
- Company expects to trade on OTC Markets under same ticker SCPS; has applied for the OTCQB Venture Market.
- No assurance OTCQB application will be approved or that company can satisfy ongoing reporting requirements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1772028/000110465922127517/0001104659-22-127517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1772028/000110465922127517/tm2232869d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-127517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer